Table 1.
Primer | Sequence (5′–3′) | Source |
---|---|---|
LB-F | GCGGGCCCAGGCTACTATGGCTGTT | This study |
LB-R | GCGAGCTCAGATGCGAAAGGGTC | This study |
RB-F | GGAAGCTTCAATCCCGTTGTTCTGGT | This study |
RB -R | GGACTAGTAGCCTGCTTCGTGTTCC | This study |
P1-F | CTTTTCTCTTAGGTTTACCCG | [31] |
P2-R | TAATGCAGGAGTCGCATAAG | [31] |
P3-F | CCCAAAAAGTGCTCCTTCAA | [31] |
P4-R | TGTGCTGCAAGGCGATTAA | [31] |
ΔJ-U-F | CCTCGGGCGGTCTGTTT | This study |
ΔJ-U-R | TTCGGCGTGGGTATGG | This study |
ΔJ-D-F | TCCTCGTTCCTGTCTG | This study |
ΔJ-D-R | CTCCGATGATGAGAAGT | This study |
C-FgABCC9-F | TGCCATGGTATTACCGTACTTCCCTA | This study |
C-FgABCC9-R | GGACTAGTCGACTGTCTACTCGACTC | This study |
CJ-FgABCC9-F | AAGAAGGCAAAGAAAGCAAA | This study |
CJ-FgABCC9-R | GAACAAGGCCAGTGATGAGA | This study |
Fg-GAPDH-F | TGACTTGACTGTTCGCCTCGAGAA | [24] |
Fg-GAPDH-R | ATGGAGGAGTTGGTGTTGCCGTTA | [24] |
Fg-β-tubulin-F | GTTGATCTCCAAGATCCGTG | [24] |
Fg-β-tubulin-R | CATGCAAATGTCGTAGAGGG | [24] |
Fg-elongation Factor1-F | CCTCCAGGATGTCTACAAGA | [24] |
Fg-elongation Factor1-R | CTCAACGGACTTGACTTCAG | [24] |
Aox-F | GACTTGTCATGGTAGATGCCTG | [24] |
Aox-R | CAGGACGAGCATAACCATTCTC | [24] |
w-GAPDH-F | AACTGTTCATGCCATCACTGCCAC | [24] |
w-GAPDH-R | AGGACATACCAGTGAGCTTGCCAT | [24] |
hn-RNP-Q-F | TCACCTTCGCCAAGCTCAGAACTA | [24] |
hn-RNP-Q-R | AGTTGAACTTGCCCGAAACATGCC | [24] |
Rj-FgABCC9-F | GCGGGACCACAAGGGATT | This study |
Rj-FgABCC9-R | GATGTAGGCACCGTAGACAGACC | This study |
ACT2-F | CTTGCACCAAGCAGCATGAA | [42] |
ACT2-R | CCGATCCAGACACTGTACTTCCTT | [42] |
UBQ10-F | GGCCTTGTATAATCCCTGATGAATAAG | [42] |
UBQ10-R | AAAGAGATAACAGGAACGGAAACATAGT | [42] |
EF-1α-F | TGAGCACGCTCTTCTTGCTTTCA | [42] |
EF-1α-R | GGTGGTGGCATCCATCTTGTTACA | [42] |
EDS1-F | GGATAGAAGATGAATACAAGCC | [43] |
EDS1-R | ACCTAAGGTTCAGGTATCTGT | [43] |
PR1F | TGGCTATTCTCGATTTTTAATCG | [29] |
PR1R | CCATTGCACGTGTTCGCAG | [29] |
NPR1-F | CATTCTCTCAAAGGCCGACT | [44] |
NPR1-R | AAGACGTTGAGCAAGTGCAA | [44] |
PAD4-F | ATGGACGATTGTCGATTCGAG | [43] |
PAD4-R | CTAAGTCTCCATTGCGTCACT | [43] |
The underlined are cutting sites for restriction enzymes.